Bausch & Lomb Q3 2026 Results: Turns Profitable, Net Income $32M
Bausch + Lomb Corp filed its Q3 2026 Form 10-Q reporting 357,497,374 common shares outstanding as of October 21, 2026. The filing highlights significant macroeconomic risks including inflation, interest rate fluctuations, and the impact of U.S. trade tariffs, while continuing to plan for its eventual separation from Bausch Health Companies Inc.
- Key figure
- Net income $32M